ARROWHEAD PHARMACEUTICALS IN

Ticker: ARWR CUSIP: 04280A100 Class: Common Stock

Connor, Clark & Lunn Investment Management Ltd.'s Holding History (CIK: 0001596800)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 663,262 Value ($000) $44,034 Avg Close $49.01 Range $34.38 - $72.36

Q3 2025

Shares 124,529 Value ($000) $4,295 Avg Close $21.98 Range $14.30 - $34.61

Q4 2022

Shares 17,340 Value ($000) $703 Avg Close $33.13 Range $27.75 - $40.62

Q3 2022

Shares 46,843 Value ($000) $1,548 Avg Close $40.36 Range $29.60 - $48.48

Q2 2022

Shares 86,793 Value ($000) $3,056 Avg Close $37.62 Range $26.81 - $51.11

Q1 2022

Shares 66,474 Value ($000) $3,057 Avg Close $49.51 Range $38.89 - $70.09

Q4 2021

Shares 31,878 Value ($000) $2,114 Avg Close $68.71 Range $57.94 - $84.83

Q3 2021

Shares 66,343 Value ($000) $4,142 Avg Close $64.75 Range $57.92 - $86.01

Q2 2021

Shares 34,970 Value ($000) $2,896 Avg Close $74.45 Range $60.52 - $93.66

Q2 2017

Shares 97,875 Value ($000) $159 Avg Close $1.62 Range $1.42 - $2.04

Q1 2017

Shares 26,100 Value ($000) $48 Avg Close $1.98 Range $1.42 - $2.45

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	663,262	$44,034	$49.01	$34.38 - $72.36
Q3 2025	124,529	$4,295	$21.98	$14.30 - $34.61
Q4 2022	17,340	$703	$33.13	$27.75 - $40.62
Q3 2022	46,843	$1,548	$40.36	$29.60 - $48.48
Q2 2022	86,793	$3,056	$37.62	$26.81 - $51.11
Q1 2022	66,474	$3,057	$49.51	$38.89 - $70.09
Q4 2021	31,878	$2,114	$68.71	$57.94 - $84.83
Q3 2021	66,343	$4,142	$64.75	$57.92 - $86.01
Q2 2021	34,970	$2,896	$74.45	$60.52 - $93.66
Q2 2017	97,875	$159	$1.62	$1.42 - $2.04
Q1 2017	26,100	$48	$1.98	$1.42 - $2.45